Published in J Clin Microbiol on October 01, 1990
Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72
Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A (2000) 5.07
Transient and persistent experimental infection of nonhuman primates with Helicobacter pylori: implications for human disease. Infect Immun (1996) 1.81
gamma-Glutamyltransferase is a Helicobacter pylori virulence factor but is not essential for colonization. Infect Immun (2001) 1.44
Characterization and presumptive identification of Helicobacter pylori isolates from rhesus monkeys. J Clin Microbiol (1994) 1.39
Experimental gastritis induced by Helicobacter pylori in Japanese monkeys. Infect Immun (1993) 1.05
Adhesion of Helicobacter pylori to gastric epithelial cells in primary cultures obtained from stomachs of various animals. Infect Immun (1993) 1.02
Helicobacter pylori infection induces duodenitis and superficial duodenal ulcer in Mongolian gerbils. Gut (2003) 0.85
Helicobacter pylori-infected animal models are extremely suitable for the investigation of gastric carcinogenesis. World J Gastroenterol (2005) 0.83
Diagnosis of Helicobacter pylori infection in a colony of rhesus monkeys (Macaca mulatta). J Clin Microbiol (1997) 0.81
A euthymic hairless mouse model of Helicobacter pylori colonization and adherence to gastric epithelial cells in vivo. Clin Diagn Lab Immunol (1998) 0.79
Deletion of cagA gene of Helicobacter pylori by PCR products. World J Gastroenterol (2005) 0.79
Establishment of BALB/c mice model infected with Helicobacter pylori. Korean J Intern Med (1999) 0.75
Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet (1983) 23.90
Characterization of three plasmid deoxyribonucleic acid molecules in a strain of Streptococcus faecalis: identification of a plasmid determining erythromycin resistance. J Bacteriol (1974) 12.44
Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust (1985) 10.75
Campylobacter pyloridis, gastritis, and peptic ulceration. J Clin Pathol (1986) 9.90
Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol (1987) 7.09
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol (1986) 5.15
Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study. Lancet (1987) 4.32
Restriction endonuclease analysis of the genome of Campylobacter pylori with a rapid extraction method: evidence for considerable genomic variation. J Infect Dis (1988) 3.96
Epidemic gastritis with hypochlorhydria. Gastroenterology (1979) 2.65
Susceptibility of Campylobacter pyloridis to 20 antimicrobial agents. Antimicrob Agents Chemother (1986) 2.26
Treatment failure of ofloxacin in Campylobacter pylori infection. Lancet (1987) 1.52
Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: a potential model for gastritis in man. Gut (1988) 1.52
Campylobacter pylori isolated from the stomach of the monkey, Macaca nemestrina. J Clin Microbiol (1988) 1.38
Campylobacter pylori-associated gastritis: a double-blind placebo-controlled trial with amoxycillin. Am J Gastroenterol (1988) 1.24
Susceptibility of clinical isolates of Campylobacter pylori to 24 antimicrobial and anti-ulcer agents. Eur J Epidemiol (1988) 1.12
Campylobacter pyloridis infection in Auckland patients with gastritis. N Z Med J (1986) 1.00
[Campylobacter pylori, gastritis and peptic ulcer]. Wien Klin Wochenschr (1987) 0.96
Identification of Campylobacter pylori by using the rapID NH system. J Clin Microbiol (1989) 0.93
Campylobacter-like organisms in the gastric mucosa of rhesus monkeys. Lab Anim Sci (1988) 0.88
Study of oesophagus, stomach and duodenum of 100 Rhesus monkeys. J Assoc Physicians India (1966) 0.80
Characterization of three plasmid deoxyribonucleic acid molecules in a strain of Streptococcus faecalis: identification of a plasmid determining erythromycin resistance. J Bacteriol (1974) 12.44
Mapping of Streptococcus faecalis plasmids pAD1 and pAD2 and studies relating to transposition of Tn917. J Bacteriol (1982) 7.03
Modification of Streptococcus faecalis sex pheromones after acquisition of plasmid DNA. Proc Natl Acad Sci U S A (1983) 5.27
Recombination-deficient mutant of Streptococcus faecalis. J Bacteriol (1980) 4.60
Plasmid-determined tetracycline resistance in Streptococcus faecalis: evidence for gene amplification during growth in presence of tetracycline. Proc Natl Acad Sci U S A (1975) 4.21
Plasmid content of Streptococcus faecalis strain 39-5 and identification of a pheromone (cPD1)-induced surface antigen. J Gen Microbiol (1983) 3.80
Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. J Med Chem (1996) 2.82
Plasmid-determined tetracycline resistance in Streptococcus faecalis: tandemly repeated resistance determinants in amplified forms of pAMalpha1 DNA. J Mol Biol (1976) 2.79
Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47
Number of binding sites of rabbit macroglobulin antibody and its subunits. Immunochemistry (1965) 2.16
Identification and characterization of a small sequence located at two sites on the amplifiable tetracycline resistance plasmid pAMalpha1 in Streptococcus faecalis. J Bacteriol (1977) 2.16
Plaque assay for Ebola virus. J Clin Microbiol (1981) 1.99
Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: a resource for investigations into drug disposition. Xenobiotica (2006) 1.96
Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol (2001) 1.91
Characterization of a small plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain of Streptococcus sanguis isolated from dental plaque. Antimicrob Agents Chemother (1978) 1.89
Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol (2007) 1.87
Identification and partial characterization of a pheromone-induced adhesive surface antigen of Streptococcus faecalis. J Bacteriol (1983) 1.86
Hypomethylation of LINE1 retrotransposon in human hepatocellular carcinomas, but not in surrounding liver cirrhosis. Jpn J Clin Oncol (2000) 1.84
Toxicity of staphylococcal enterotoxins potentiated by lipopolysaccharide: major histocompatibility complex class II molecule dependency and cytokine release. Infect Immun (1993) 1.69
Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol Lett (2001) 1.59
Patterns of human antibody reactions in coccidioidomycosis. J Bacteriol (1966) 1.57
Therapeutic effects of ribavirin given by the intraperitoneal or aerosol route against influenza virus infections in mice. Antimicrob Agents Chemother (1976) 1.55
IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity. Proc Soc Exp Biol Med (1965) 1.55
Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity. J Med Chem (1996) 1.54
Three different types of dry eye syndrome. Cornea (1994) 1.53
Pathogenesis of a pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun (1981) 1.51
Importance of left ventricular function and systolic ventricular interaction to right ventricular performance during acute right heart ischemia. J Am Coll Cardiol (1992) 1.51
Immunoglobulin production in human leukemia cell lines. J Immunol (1966) 1.47
Enhancement of adipocyte differentiation by an insulin-sensitizing agent. Mol Pharmacol (1992) 1.46
Modification of the error-rate bounded classification scheme for use with two MIC break points. Diagn Microbiol Infect Dis (1992) 1.46
A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill (2011) 1.45
Inactivation of Serpulina hyodysenteriae flaA1 and flaB1 periplasmic flagellar genes by electroporation-mediated allelic exchange. J Bacteriol (1995) 1.42
Immunoadsorbents with high capacity. Immunochemistry (1965) 1.39
Isolation of rabbit IgA antihapten antibody and demonstration of skin-sensitizing activity in homologous skin. J Exp Med (1966) 1.37
Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immunoglobulin level with the generation cycle. J Immunol (1969) 1.36
Treatment of influenza infection of mice by using rimantadine hydrochlorides by the aerosol and intraperitoneal routes. Antimicrob Agents Chemother (1975) 1.34
Tear function index. A new measure of dry eye. Arch Ophthalmol (1995) 1.30
HL-A antigens from hematopoietic cell lines: molecular size and electrophoretic mobility. J Immunol (1971) 1.28
Functional and morphologic changes during experimental Rocky Mountain spotted fever in guinea pigs. Lab Invest (1976) 1.28
Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay. J Immunol Methods (1973) 1.26
Development and experience with an integrated system for transplantation telepathology. Hum Pathol (2001) 1.23
Mucosal vaccination with recombinantly attenuated staphylococcal enterotoxin B and protection in a murine model. Infect Immun (2001) 1.23
Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium. J Immunol (1969) 1.23
Monoclonal antibodies against human DNA polymerase-alpha inhibit DNA replication in permeabilized human cells. J Biol Chem (1985) 1.20
Interaction of a neuron-specific protein containing PDZ domains with Alzheimer's amyloid precursor protein. J Biol Chem (1999) 1.20
Immunoglobulin M antibodies with ten combining sites. Science (1968) 1.18
An efficient method for isolation of HL-A antigens from hematopoietic cell lines. J Immunol (1971) 1.18
Decrease in corneal sensitivity and change in tear function in dry eye. Cornea (1996) 1.17
Amplification of the tetracycline resistance determinant of plasmid pAM alpha 1 in Streptococcus faecalis: dependence on host recombination machinery. J Bacteriol (1980) 1.17
Characterization of early gastric cancer and proposal of the optimal therapeutic strategy. Surgery (2001) 1.15
Evaluation of fibergastroscopic biopsy in the diagnosis of gastric cancer: a study of 339 cases. Gastroenterol Jpn (1978) 1.15
Inactivated vaccine for Ebola virus efficacious in guineapig model. Lancet (1980) 1.14
Synthesis and antimicrobial activity of clindamycin analogues: pirlimycin, 1,2 a potent antibacterial agent. J Med Chem (1984) 1.13
Superantigen vaccines: a comparative study of genetically attenuated receptor-binding mutants of staphylococcal enterotoxin A. J Infect Dis (1996) 1.12
Serum inhibitory titers and serum bactericidal titers for human subjects receiving multiple doses of the antibacterial oxazolidinones eperezolid and linezolid. Diagn Microbiol Infect Dis (1997) 1.11
Immunoglobulin production in cloned sublines of a human lymphocytoid cell line. J Immunol (1969) 1.11
IL-15-induced conversion of monocytes to mature dendritic cells. Clin Exp Immunol (2001) 1.10
Steep rise in notified hantavirus infections in Germany, April 2010. Euro Surveill (2010) 1.10
Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM. J Immunol (1973) 1.10
Extensive proliferation of mature connective-tissue type mast cells in vitro. Nature (1986) 1.10
Protection against Staphylococcus aureus sepsis by vaccination with recombinant staphylococcal enterotoxin A devoid of superantigenicity. J Infect Dis (1999) 1.08
The effect of dissolved oxygen partial pressure on growth, metabolism and immunoglobulin production in a permanent human lymphocyte cell line culture. Proc Soc Exp Biol Med (1972) 1.07
The discovery of linezolid, the first oxazolidinone antibacterial agent. Curr Drug Targets Infect Disord (2001) 1.07
Association of Treponema hyodysenteriae with porcine intestinal mucosa. J Gen Microbiol (1988) 1.07
Common antigen structures of HL-A antigens. I. Antigenic determinants recognizable by rabbits on papain-solubilized HL-A molecular fragments. Immunology (1973) 1.06
Limited tryptic digestion of messenger RNA capping enzyme from Artemia salina. Isolation of domains for guanylyltransferase and RNA 5'-triphosphatase. J Biol Chem (1984) 1.06
Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. J Infect Dis (1999) 1.05
Human transplantation antigens: isolation and radioimmunoassay. Proc Soc Exp Biol Med (1971) 1.05
Pathogenesis of tularemia in immune and nonimmune rats. Am J Vet Res (1975) 1.04
Application of the paired label radioantibody technique to tissue sections and cell smears. J Immunol (1967) 1.04
Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg (2001) 1.02
Protective activity of thymosin against opportunistic infections in animal models. Cancer Immunol Immunother (1983) 1.01
Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. J Med Chem (1998) 1.01
Relationship of serum beta-glucuronidase and lysozyme to pathogenesis of tularemia in immune and nonimmune rats. Infect Immun (1975) 1.01
Presence of two different immunoglobulin heavy chains in individual cells of established human hematopoietic cell lines. J Immunol (1968) 1.01
Separation of antibodies into fractions with different binding properties. Immunochemistry (1967) 1.00
Induced metabolic sequelae of tularemia in the rat: correlation with tissue damage. Am J Physiol (1975) 0.99
TNF-alpha mediates the development of anaemia in a murine Trypanosoma brucei rhodesiense infection, but not the anaemia associated with a murine Trypanosoma congolense infection. Clin Exp Immunol (2005) 0.99
Improvement of corneal sensation and tear dynamics in diabetic patients by oral aldose reductase inhibitor, ONO-2235: a preliminary study. Cornea (1996) 0.98
Inhibition of DNA replication and DNA polymerase alpha activity by monoclonal anti-(DNA polymerase alpha) immunoglobulin G and F(ab) fragments. Biochemistry (1985) 0.98
Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells. J Immunol (1971) 0.98
Silencing of HTR1B and reduced expression of EDN1 in human lung cancers, revealed by methylation-sensitive representational difference analysis. Oncogene (2001) 0.98
Involvement of three or more lymph nodes predicts poor prognosis in submucosal gastric carcinoma. Gastric Cancer (2001) 0.97
Monoclonal IgA and IgM in the serum of a single patient (SC). 3. Immunofluorescent identification of cells producing IgA and IgM. J Immunol (1973) 0.97
Involvement of dendritic cells in sarcoidosis. Thorax (2004) 0.96
Insulin allergy and insulin resistance. Case report with immunologic studies. J Allergy (1970) 0.96
Compendium of gene expression profiles comprising a baseline model of the human liver drug metabolism transcriptome. Xenobiotica (2006) 0.96
3-Arylpiperidines as potentiators of existing antibacterial agents. Bioorg Med Chem Lett (2001) 0.95
Association of an RNA 5'-triphosphatase activity with RNA guanylyltransferase partially purified from rat liver nuclei. EMBO J (1983) 0.94
Assessment of autonomic nervous function by power spectral analysis of heart rate variability in the horse. J Auton Nerv Syst (1996) 0.94
Rise in the number of notified human hantavirus infections since October 2011 in Baden-Wurttemberg, Germany. Euro Surveill (2012) 0.94
Phase I/II study of intraperitoneal docetaxel plus S-1 for the gastric cancer patients with peritoneal carcinomatosis. Cancer Chemother Pharmacol (2013) 0.94
An ORF1-rearranged hepatitis E virus derived from a chronically infected patient efficiently replicates in cell culture. J Viral Hepat (2013) 0.93
Superconductivity in thin films of boron-doped carbon nanotubes. Phys Rev Lett (2008) 0.93
Pterygium and dry eye. Ophthalmologica (2001) 0.92
Alterations in coagulation and fibrinolysis during sepsis. Shock (1996) 0.92